Skip to main content

ALENDRONATE SODIUM

NDC 69097-223 · Cipla USA Inc.

Generic nameAlendronate sodium
Dosage formTABLET
RouteORAL
Active ingredient(s)ALENDRONATE SODIUM
Strength35 mg/1
Pharmacologic classBisphosphonate [EPC], Diphosphonates [CS]
Marketing categoryANDA

Packages

69097-223-16 — 1 BLISTER PACK in 1 CARTON (69097-223-16) / 4 TABLET in 1 BLISTER PACK

69097-223-76 — 3 BLISTER PACK in 1 CARTON (69097-223-76) / 4 TABLET in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

60723-207 — ALENDRONATE SODIUM, 64980-340 — Alendronate Sodium, 64980-341 — Alendronate Sodium, 64980-342 — Alendronate Sodium, 65862-327 — Alendronate Sodium, 65862-328 — Alendronate Sodium, 65862-329 — Alendronate Sodium, 68071-3340 — Alendronate sodium, 68071-3771 — Alendronate sodium, 68788-7130 — Alendronate sodium, 69097-224 — Alendronate sodium, 70518-0033 — Alendronate sodium, 70518-1192 — Alendronate sodium, 70539-400 — alendronate sodium, 70954-264 — Alendronate Sodium, 71205-048 — Alendronate Sodium, 76282-681 — Alendronate sodium, 76282-682 — Alendronate sodium, 78206-135 — alendronate sodium, 78206-136 — ALENDRONATE SODIUM and CHOLECALCIFEROL, +17 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels